{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:26:01Z","timestamp":1780514761023,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["23CDA1042141"],"award-info":[{"award-number":["23CDA1042141"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5K12CA090625-24"],"award-info":[{"award-number":["5K12CA090625-24"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00485-z","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:12:00Z","timestamp":1776751920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Entrectinib results in ventricular tachycardia and Brugada phenocopy through inhibition of sodium current"],"prefix":"10.1186","volume":"12","author":[{"given":"Matthew R.","family":"Fleming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn I.","family":"Sunthankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn C.","family":"Knollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"2","key":"485_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","volume":"21","author":"RC Doebele","year":"2020","unstructured":"Doebele RC, Drilon A, Paz-Ares L, Siena S, Shaw AT, Farago AF, et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1\u20132 trials. Lancet Oncol. 2020;21(2):271\u201382.","journal-title":"Lancet Oncol"},{"issue":"1","key":"485_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/OP.20.00819","volume":"17","author":"D Almquist","year":"2021","unstructured":"Almquist D, Ernani V. The Road Less Traveled: A Guide to Metastatic ROS1-Rearranged Non-Small-Cell Lung Cancer. JCO Oncol Pract. 2021;17(1):7\u201314.","journal-title":"JCO Oncol Pract"},{"issue":"11","key":"485_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1200\/JCO.20.03025","volume":"39","author":"R Dziadziuszko","year":"2021","unstructured":"Dziadziuszko R, Krebs MG, De Braud F, Siena S, Drilon A, Doebele RC, et al. Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. J Clin Oncol. 2021;39(11):1253\u201363.","journal-title":"J Clin Oncol"},{"issue":"10","key":"485_CR4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/CIRCULATIONAHA.122.062193","volume":"147","author":"KR Bersell","year":"2023","unstructured":"Bersell KR, Yang T, Mosley JD, Glazer AM, Hale AT, Kryshtal DO, et al. Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization. Circulation. 2023;147(10):824\u201340.","journal-title":"Circulation"},{"key":"485_CR5","doi-asserted-by":"crossref","unstructured":"Cyganek L, Tiburcy M, Sekeres K, Gerstenberg K, Bohnenberger H, Lenz C et al. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes. JCI Insight. 2018;3(12):e99941.","DOI":"10.1172\/jci.insight.99941"},{"issue":"3","key":"485_CR6","doi-asserted-by":"publisher","first-page":"101560","DOI":"10.1016\/j.xpro.2022.101560","volume":"3","author":"DM Lyra-Leite","year":"2022","unstructured":"Lyra-Leite DM, Gutierrez-Gutierrez O, Wang M, Zhou Y, Cyganek L, Burridge PW. A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming. STAR Protoc. 2022;3(3):101560.","journal-title":"STAR Protoc"},{"issue":"3","key":"485_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.hrthm.2015.10.038","volume":"13","author":"M Rodriguez-Manero","year":"2016","unstructured":"Rodriguez-Manero M, Sacher F, de Asmundis C, Maury P, Lambiase PD, Sarkozy A, et al. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study. Heart Rhythm. 2016;13(3):669\u201382.","journal-title":"Heart Rhythm"},{"issue":"7","key":"485_CR8","doi-asserted-by":"publisher","first-page":"ytad324","DOI":"10.1093\/ehjcr\/ytad324","volume":"7","author":"M Kubota","year":"2023","unstructured":"Kubota M, Iso Y, Mori H, Suzuki H. Entrectinib-induced Brugada phenocopy in a patient with metastatic non-small cell lung cancer. Eur Heart J Case Rep. 2023;7(7):ytad324.","journal-title":"Eur Heart J Case Rep"},{"issue":"4","key":"485_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s13691-023-00620-y","volume":"12","author":"K Futamura","year":"2023","unstructured":"Futamura K, Hase T, Tanaka A, Sakai Y, Okachi S, Shibata H, et al. Lethal ventricular arrhythmia due to entrectinib-induced Brugada syndrome: a case report and literature review. Int Cancer Conf J. 2023;12(4):299\u2013304.","journal-title":"Int Cancer Conf J"},{"issue":"12","key":"485_CR10","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCRESAHA.121.318259","volume":"128","author":"MR Fleming","year":"2021","unstructured":"Fleming MR, Xiao L, Jackson KD, Beckman JA, Barac A, Moslehi JJ. Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. Circ Res. 2021;128(12):1973\u201387.","journal-title":"Circ Res"},{"key":"485_CR11","doi-asserted-by":"crossref","unstructured":"Fonseca M, Chen DH, Walker JM, Ghosh AK. Entrectinib-related myocarditis in a young female patient with metastatic non-small cell lung cancer. BMJ Case Rep. 2021;14(7):e243946.","DOI":"10.1136\/bcr-2021-243946"},{"issue":"1","key":"485_CR12","doi-asserted-by":"publisher","first-page":"ytae650","DOI":"10.1093\/ehjcr\/ytae650","volume":"9","author":"G Rundhawa","year":"2025","unstructured":"Rundhawa G, Ali M, Jacob R, Obeng-Gyimah E, Vranian MN. Case report of entrectinib associated fulminant myocarditis. Eur Heart J Case Rep. 2025;9(1):ytae650.","journal-title":"Eur Heart J Case Rep"},{"issue":"4","key":"485_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","volume":"7","author":"A Drilon","year":"2017","unstructured":"Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, et al. Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1). Cancer Discov. 2017;7(4):400\u20139.","journal-title":"Cancer Discov"},{"issue":"1","key":"485_CR14","first-page":"824","volume":"18","author":"A Aoyama","year":"2025","unstructured":"Aoyama A, Yoshitomi Y, Shimomura A, Kawamura Y, Taniyama T, Kurozumi A, et al. Entrectinib-Induced Pericarditis with Cardiac Tamponade in a Patient with Neurotrophic Tropomyosin Receptor Kinase 1 Fusion-Positive Breast Cancer. Case Rep Oncol. 2025;18(1):824\u20139.","journal-title":"Case Rep Oncol"},{"issue":"22","key":"485_CR15","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.jacc.2018.09.037","volume":"72","author":"M Pieroni","year":"2018","unstructured":"Pieroni M, Notarstefano P, Oliva A, Campuzano O, Santangeli P, Coll M, et al. Electroanatomic and Pathologic Right Ventricular Outflow Tract Abnormalities in Patients With Brugada Syndrome. J Am Coll Cardiol. 2018;72(22):2747\u201357.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"485_CR16","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.112.000901","volume":"127","author":"V Kumar","year":"2013","unstructured":"Kumar V, Patel N, Van Houzen N, Saini N. Brugada-type electrocardiographic changes induced by fever. Circulation. 2013;127(21):2145\u20136.","journal-title":"Circulation"},{"key":"485_CR17","first-page":"118","volume":"1","author":"NJ Gurule","year":"2018","unstructured":"Gurule NJ, Heasley LE. Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses. Cancer Drug Resist. 2018;1:118\u201325.","journal-title":"Cancer Drug Resist"},{"issue":"4","key":"485_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/mi.2014.109","volume":"8","author":"M Rochman","year":"2015","unstructured":"Rochman M, Kartashov AV, Caldwell JM, Collins MH, Stucke EM, Kc K, et al. Neurotrophic tyrosine kinase receptor 1 is a direct transcriptional and epigenetic target of IL-13 involved in allergic inflammation. Mucosal Immunol. 2015;8(4):785\u201398.","journal-title":"Mucosal Immunol"},{"key":"485_CR19","first-page":"4063562","volume":"2020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, et al. NLRP3 Inflammasome and Inflammatory Diseases. Oxid Med Cell Longev. 2020;2020:4063562.","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"485_CR20","doi-asserted-by":"publisher","first-page":"101310","DOI":"10.1016\/j.xcrm.2023.101310","volume":"4","author":"X Jin","year":"2023","unstructured":"Jin X, Liu D, Zhou X, Luo X, Huang Q, Huang Y. Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7. Cell Rep Med. 2023;4(12):101310.","journal-title":"Cell Rep Med"},{"issue":"1","key":"485_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","volume":"20","author":"AA Zarrin","year":"2021","unstructured":"Zarrin AA, Bao K, Lupardus P, Vucic D. Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov. 2021;20(1):39\u201363.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00485-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:12:03Z","timestamp":1776751923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00485-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00485-z","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Institutional Review Board at Vanderbilt University Medical Center, Nashville, Tennessee (IRB # 9047).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}